Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil confirms sugar cane extensions

Brazil’s national health surveillance agency, the Anvisa, has confirmed use extensions on sugar cane for: the fungicide, metalaxyl-M; the insecticide/nematicide, cadusafos; and the insecticide, thiamethoxam. It recommended the use extensions last year ( Agrow No 582, p 21). Industry sources say that the agency has also approved the use of the insecticide, lufenuron, on sugar cane as a foliar application, while recommending a use extension on the same crop for the fungicide, fludioxonil. The lufenuron extension was subject to public comments from October last year. It was already approved on several crops including cotton, citrus fruit, maize, soybeans and wheat. The recommendation for fludioxonil is as an “industrial treatment of vegetative seedlings before planting, and is subject to a 30-day comment period. It is already approved in seed treatments on eight crops, including cotton, maize and soybeans.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG001579

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel